Sommario

• • ·Editorial Board

    Articolo :100687

    
• • ·Content

    Articolo :100688

    

• Editorials

  • ·Opportunities to treat specific populations with repurposed drugs

    Articolo :100671

    Serge Gauthier

    Mappa Mappa
  • ·What's good for the heart is good for the brain? Evidence from a rural cohort on the longitudinal relationship between atherosclerotic cardiovascular disease risk and cognitive decline

    Articolo :100672

    Maileen G. Ulep

    Mappa Mappa
  • ·From advice to agency: making brain health actionable and equitable for middle-aged adults with mild neurocognitive disorder

    Articolo :100667

    Hermine Lenoir

    Mappa Mappa
  • ·Frailty in the anti-amyloid era: an opportunity to individualize care

    Articolo :100682

    Nicholas M. Vogt, Dae Hyun Kim

    Mappa Mappa

• Original articles

  • ·Risk of Dementia after initiation of GLP-1 RA versus long-acting insulin in patients with type 2 Diabetes mellitus

    Articolo :100645

    Chien-Hung Lin, Peir-Haur Hung, Mu-Chi Chung, Laing-You Wu, Chi-Jung Chung

    Riassunto Riassunto Mappa Mappa   
  • ·Increasing cardiovascular disease risk predicts faster cognitive decline: A Bayesian analysis of a cohort of adults in rural West Texas

    Articolo :100651

    Chathurika S. Dhanasekara, Chanaka N. Kahathuduwa, Volker Neugebauer

    Riassunto Riassunto Mappa Mappa   

• Reviews

  • ·Brain health strategies in middle-aged individuals with mild neurocognitive disorder: a scoping review

    Articolo :100657

    Joshi Dookhy, Yvonne McCague, Jim Hickson, Diarmuid Stokes, Thilo Kroll, Kate Frazer

    Riassunto Riassunto Mappa Mappa   
  • ·Integrating frailty into decision-making for disease-modifying therapies in Alzheimer’s disease: a proposed expert-opinion based approach

    Articolo :100666

    Giuseppe Bellelli, Ovidio Brignoli, Marco Canevelli, Antonio Cherubini, Andrew Clegg, Bruno Dubois, Maria Cristina Ferrara, Laura Fratiglioni, Giovanni B. Frisoni, Giulia Grande, Frank Jessen, Sean P Kennelly, Alberto Magni, Martina Marelli, Alessandra Marengoni, Nicolás Martínez Velilla, Susan D. Shenkin, Marc Suárez-Calvet, Suzanne Timmons, Alessandro Padovani

    Riassunto Riassunto Mappa Mappa  

• Original article

  • ·Comprehensive social determinants of health and brain health in midlife

    Articolo :100652

    Christina S. Dintica, Julia Cheunkarndee, R. Nick Bryan, Lenore J. Launer, Kristine Yaffe

    Riassunto Riassunto Mappa Mappa   

• Short communication

  • ·The missing improvers: Tau pathology, neuroplasticity, and the case for tau-informed patient selection before amyloid immunotherapy

    Articolo :100653

    Eric Dinnerstein

    Riassunto Riassunto Mappa Mappa

• Brief report

  • ·Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181

    Articolo :100664

    Moeko Noguchi-Shinohara, Daiki Muramatsu, Ayano Shima, Yasuhiro Sakashita, Yasutake Tada, Hiroki Yamaguchi, Junji Komatsu, Tokuhei Ikeda, Kenjiro Ono

    Riassunto Riassunto Mappa Mappa   

• Original article

  • ·Relative importance of blood-based biomarkers for Alzheimer’s disease-specific neurodegeneration and cognitive decline

    Articolo :100644

    Keun You Kim, Hyunsun Ham, Eun Jin Yoon, Eosu Kim, Yu Kyeong Kim, Jun-Young Lee, Alzheimer’s Disease Neuroimaging Initiative

    Riassunto Riassunto Mappa Mappa   

• Review

  • ·Psychological adversities and epigenetic ageing in midlife and older age: A systematic review and meta-analysis

    Articolo :100650

    Jiuyu Guo, Jiatong Shan, Kaisy Xinhong Ye, Wei Liang, Yanyu Wang, Eng-Tat Ang, Tih-Shih Lee, John Suckling, Andrea B. Maier, Lei Feng

    Riassunto Riassunto Mappa Mappa   

• Original articles

  • ·Timing of cognitive decline onset and life-course trajectories A pooled longitudinal analysis of 14,389 adults across three cohorts

    Articolo :100649

    Jan Sebastian Novotný, Sivan Klil-Drori, Yonas Endale Geda, Ziad Nasreddine, Gorazd Bernard Stokin

    Riassunto Riassunto Mappa Mappa   
  • ·Cost-effectiveness of the special care unit for persons with dementia

    Articolo :100647

    Ron Handels, Bernhard Michalowsky, Aline Mendes, Sverre Bergh, Bruno Mario Cesana, Alfonso Ciccone, Emmanuel Cognat, Andrea Fabbo, Sara Fascendini, Giovanni B. Frisoni, Lutz Froelich, Patrizia Mecocci, Paola Merlo, Oliver Peters, Magdalini Tsolaki, Carlo Alberto Defanti, RECage consortium collaborators

    Riassunto Riassunto Mappa Mappa   
  • ·Quantifying generalization error in machine learning prediction of cognitive decline

    Articolo :100646

    Roya Melanie Hüppi, Nicolas Langer, Bruno Hebling Vieira, for the Alzheimer’s Disease Neuroimaging Initiative

    Riassunto Riassunto Mappa Mappa   
  • ·Choroid plexus volume in pathology-confirmed Alzheimer's disease

    Articolo :100648

    Francis Fernandes, Avyarthana Dey, Andy Ma, Nathan W. Churchill, Corinne E. Fischer, Simon J. Graham, David G. Munoz, Tom A. Schweizer

    Riassunto Riassunto Mappa Mappa   
  • ·Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia

    Articolo :100658

    Berta Calm, Adrián Hinojosa-Calleja, Fernando García-Gutiérrez, Josep Blazquez-Folch, Montserrat Alegret, Maria Victoria Fernández, Itziar De Rojas, Pablo García-González, Clàudia Olivé, Alejandro Valenzuela-Seba, Paula Bayón-Buján, Amanda Cano, Raquel Puerta, Maria Capdevila-Bayo, Álvaro Muñoz-Morales, Andrea Miguel, Ariadna Solivar, Laura Montrreal, Pilar Sanz-Cartagena, Maitee Rosende-Roca, Yahveth Cantero-Fortiz, Miren Jone Gurruchaga, Lluís Tárraga, Mercè Boada, Marta Marquié, Agustín Ruiz, Sergi Valero, Alzheimer’s Disease Neuroimaging Initiative

    Riassunto Riassunto Mappa Mappa   
  • ·Prevalence of dementia and BPSD in community-dwelling older adults with advanced care needs: a nationwide survey in Taiwan

    Articolo :100656

    Kai-Ming Jhang, Yu-Chun Tung, Wen-Fu Wang, Hsiang-Ju Chung, Hui-Yi Liao, Ling-Chun Huang, Chih-Cheng Hsu, Yuan-Han Yang

    Riassunto Riassunto Mappa Mappa  
  • ·National Prevalence and Care Needs of Dementia in Adults Aged >=55 Years: Findings from the China Mental Health Survey

    Articolo :100659

    Zhaorui Liu, Guangming Xu, Ruoxi Ding, Chao Ma, Yueqin Huang, Lingjiang Li, Tingting Zhang, Jie Yan, Yaqin Yu, Xiufeng Xu, Zhizhong Wang, Yifeng Xu, Tao Li, Huifang Yin, Xiangdong Xu, Limin Wang, Yongping Yan, Shuiyuan Xiao

    Riassunto Riassunto Mappa Mappa  

• Letters to the editor

  • ·From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network

    Articolo :100655

    Giovanna Zamboni, Manuela Tondelli, Giulia Vinceti, Chiara Gallingani, Zeno Bercini, Aurora Barbieri, Chiara Carbone, Najara Iacovino, Silvia Cossutti, Daniela Ballotta, Simone Salemme, Annalisa Chiari

    Mappa Mappa  
  • ·Oxidation over omega-3: Reinterpreting the paradoxical link between fish oil supplements and accelerated cognitive decline

    Articolo :100660

    Dong'e Huang, Munan Lin, Junqing Dong

    Riassunto Riassunto Mappa Mappa
  • ·Do methodological limitations and confounding factors explain the apparent acceleration of cognitive decline in older adults taking omega-3 fatty acid supplements?

    Articolo :100661

    Simon C. Dyall, Mélanie Plourde

    Riassunto Riassunto Mappa Mappa
  • ·Response to two letters on omega-3 supplementation and cognitive decline

    Articolo :100662

    Zheng-Bin Liao, Ye-Ran Wang

    Mappa Mappa

• Corrigendum

  • ·Corrigendum to “Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181” [The Journal of Prevention of Alzheimer's Disease (2026) 100664]

    Articolo :100668

    Moeko Noguchi-Shinohara, Daiki Muramatsu, Ayano Shima, Yasuhiro Sakashita, Yasutake Tada, Hiroki Yamaguchi, Junji Komatsu, Tokuhei Ikeda, Kenjiro Ono